Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Contribution of Functional Brain MRI to the Understanding of Arthrogenic Muscle Inhibition (AMI) in the Aftermath of Knee Trauma.

NCT03950024 is registered in ClinicalTrials.gov with University Hospital, Toulouse as lead sponsor.

NCT NCT03950024
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03950024 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Contribution of Functional Brain MRI to the Understanding of Arthrogenic Muscle Inhibition (AMI) in the Aftermath of Knee Trauma.
Lead sponsor
University Hospital, Toulouse
Phase
Not applicable
Overall status
Completed
Start date
October 29, 2019
Completion date
June 11, 2024
Enrollment
42 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anterior cruciate ligament rupture